| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000064071 |
| P698 | PubMed publication ID | 12372957 |
| P2093 | author name string | Takashi Sugawara | |
| Jun Nakajima | |||
| Jun Soma | |||
| Minoru Kawamura | |||
| Yee-Der Huang | |||
| P433 | issue | 3 | |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | 693-698 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | The Nephron Journals | Q15745443 |
| P1476 | title | Tranilast slows the progression of advanced diabetic nephropathy | |
| P478 | volume | 92 |
| Q28484321 | A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat |
| Q37887401 | Antifibrotic treatment and other new strategies for improving renal outcomes |
| Q39504175 | Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus |
| Q82929879 | Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model |
| Q35927429 | Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans |
| Q37489497 | Emerging therapies for chronic kidney disease: what is their role? |
| Q26996407 | HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease |
| Q26768865 | Hypoxia: The Force that Drives Chronic Kidney Disease |
| Q38936622 | Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets |
| Q38062404 | Molecular targets for treatment of kidney fibrosis |
| Q38198872 | Novel targets of antifibrotic and anti-inflammatory treatment in CKD. |
| Q37904098 | Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy |
| Q26784039 | Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy |
| Q28477748 | Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis |
| Q38164537 | Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering? |
| Q46470767 | Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice |
| Q43224155 | Tranilast attenuates chronic cyclosporine nephrotoxicity in rats |
| Q46983859 | Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells |
| Q35700386 | Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats |
Search more.